Venoruton 1000mg 30 sachets granules

Venoruton 1000mg 30 granulated sachets is a product formulated for the treatment of symptoms associated withvenous insufficiency and to the states of capillary fragility. Each sachet contains oxerutin 1000 mg, an active ingredient known for its beneficial properties on venous circulation. This granules are designed to be dissolved in water, facilitating the intake and absorption of the active ingredient. Venoruton is particularly suitable for those seeking effective support in the management of venous disorders, helping to improve the well-being of the legs. The sachet formulation offers convenience and flexibility in dosage, adapting to individual needs.

INDICATIONS

Why is Venoruton 1000mg 30 sachets granulated used? What is it for?

Venoruton is indicated in the treatment of symptoms related to venous insufficiency; states of capillary fragility.

ACTIVE INGREDIENTS AND EXCIPIENTS

What is the composition of Venoruton 1000mg 30 sachets granules?

Composition

Venoruton 1000 mg powder: One sachet contains - Active ingredient: oxerutin 1000 mg. Venoruton 500 mg coated tablets: One tablet contains: Active ingredient oxerutin 500 mg. Excipients with known effects: sunset yellow aluminum lake (E 110) (2.68 mg/tablet). Venoruton 2% gel: 100 g of gel contains: Active ingredient oxerutin 2 g. Excipients with known effects: benzalkonium chloride 0.05 mg/g.

Excipients

Venoruton 1000 mg powder: mannitol; sodium saccharin; citric acid monohydrate. Venoruton 500 mg coated tablets: polyacrylate dispersion 30 percent; talc; magnesium stearate; macrogoli; copovidone; sunset yellow aluminum lacquer (E 110); titanium dioxide. Venoruton 2% gel for cutaneous use: carbomers; sodium hydroxide; disodium edetate; benzalkonium chloride; purified water.

DOSAGE

How is Venoruton 1000mg 30 sachets granulated taken?

Venoruton 1000 mg powder: 2 to 3 sachets per day, depending on the severity of the symptom. The contents of each sachet of powder should be carefully dissolved in a little water and taken before or during meals, even in venous insufficiency of the hemorrhoidal plexus. Venoruton 500 mg coated tablets: 2 - 3 tablets per day. The tablets should be swallowed whole with a little water, without chewing, before or during meals, even in venous insufficiency of the haemorrhoidal plexus. Venoruton 2% gel for cutaneous use: apply an adequate quantity of gel both on the area affected by the disorder and on the surrounding areas, 2 times a day (morning and evening). Massage lightly to allow the medicine to penetrate until completely absorbed, that is, until the skin feels dry upon contact with your hands. Do not exceed the recommended doses. Use only for short treatment periods.

CONTRAINDICATIONS AND SIDE EFFECTS

When should Venoruton 1000mg 30 sachets granules not be used and what side effects can it cause?

Contraindications

Hypersensitivity to the active substance or to any of the excipients (see the section "What is the composition of Venoruton 1000mg 30 granules sachets?").

Side effects

Venoruton oral formulations: Safety profile summary Venoruton may in rare cases cause gastrointestinal side effects or skin reactions such as gastrointestinal disorders, flatulence, diarrhoea, abdominal pain, stomach discomfort, dyspepsia, rash, itching or hives. Very rare is the appearance of dizziness, headache, hot flashes, tiredness or hypersensitivity reactions such as anaphylactoid reactions. Table of adverse reactions Side effects are listed below by system organ class and frequency. Frequencies are defined as: very common (≥ 1/10), common (≥ 1/100 to less than 1/10); uncommon (≥ 1/1,000 to less than 1/100); rare (≥ 1/10,000 to less than 1,000); very rare (less than 1/10,000), or not known (frequency cannot be estimated from the available data). Within each frequency class, undesirable effects are indicated in order of decreasing seriousness. Classes Organ Systems / Frequency Adverse reactions Immune system disorders Very rare Anaphylactoid reactions Very rare Hypersensitivity reactions Nervous system disorders Very rare Dizziness Very rare Headache Vascular pathologies Very rare Flushing Gastrointestinal disorders Rare Gastrointestinal disorders Rare Flatulence Rare Diarrhea Rare Abdominal pain Rare Stomach disorders Rare Dyspepsia Pathologies of the skin and subcutaneous tissue Rare Rash Rare Pruritus Rare Urticaria Systemic pathologies and conditions relating to the administration site Very rare Fatigue Venoruton gel: Safety profile summary Venoruton gel is well tolerated. Rare cases of sensitization with the appearance of skin reactions have been observed. These symptoms disappear when treatment is stopped. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

INTERACTIONS

Which medicines or foods can modify the effect of Venoruton 1000mg 30 sachets granules?

To date, no specific interaction of oxerutin with other medicinal products has been reported. In vitro data on a possible modulation of CYP3A activity by oxerutin components (quercetin and rutin present in trace amounts) are conflicting. Venoruton gel: no interactions with medicinal products have been reported.

PREGNANCY AND BREASTFEEDING

Can Venoruton 1000mg 30 granulated sachets be used during pregnancy and breastfeeding?

Pregnancy The safety of the drug in pregnancy has not been established, therefore it is not recommended during pregnancy. Breastfeeding In animal studies, traces of oxerutin have been found in breast milk. It is assumed that the small quantities of oxerutin that pass into breast milk can be considered to have no clinical relevance for humans. Fertility Animal studies have shown no effects on fertility after administration of oxerutin.

WARNINGS

What are the warnings of Venoruton 1000mg 30 sachets granules?

Warnings and precautions

Patients suffering from lower limb edema due to heart, kidney or liver disease should not take Venoruton as the effect of Venoruton is not proven in these indications. Pediatric population The use of Venoruton is not recommended in children. Venoruton gel: The use, especially if prolonged, of products to be applied to the skin can give rise to sensitization phenomena. In this case you should stop treatment and contact your doctor to institute suitable therapy. Important information about some excipients Venoruton 1000 mg powder contains: - sodium saccharin: this medicinal product contains less than 1 mmol (23 mg) sodium per dose, i.e. essentially 'sodium-free'. Venoruton 500 mg film-coated tablets contain the azo coloring agent: - sunset yellow aluminum lake (E 110): may cause allergic reactions. Venoruton gel contains: - benzalkonium chloride: this medicinal product contains 0.391 mg of benzalkonium chloride per dose equivalent to 0.05 mg/g. Benzalkonium chloride may irritate the skin. If you are breastfeeding, do not apply this medicine to your breasts because your baby may ingest it with his milk.

Overdose

No case of overdose has ever been reported.

Driving vehicles and using machinery

Venoruton has no or negligible influence on the ability to drive or use machines. In rare cases, tiredness and dizziness have been reported in patients taking the product. Affected patients are advised not to drive or use machinery. Venoruton gel does not alter the ability to drive and use machines.

CONSERVATION

How is Venoruton 1000mg 30 sachets granulated stored?

This medicinal product does not require any special storage conditions.

FORMAT

What is the format of Venoruton 1000mg 30 sachets granules?

30 sachets of granules

DRUG LEGAL TEXT

Content responsibility

This sheet contains information that is not intended to replace a doctor's diagnosis or advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.

Please note

The product names, ingredients and percentages indicated in the descriptions are purely indicative and may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting to these updates in real time, the photos and technical information of the products included on Dottortili.com may differ from those shown on the label or otherwise disseminated by the manufacturing companies. The only identification element appears to be the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines any responsibility for any errors, omissions or failure to update the same. Dottortili.com assumes no responsibility for damages of any nature that may arise from access to the information published.

Data source: Farmadati Italia

Website: www.farmadati.it

The Farmadati Italia database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the guarantee of historical reliability, seriousness and professionalism of the company on the national territory.

The Farmadati Italia S.r.l management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.